Larynx: Clinical Trials

2 trials for Larynx, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Larynx: new trials by email Literature Review of Larynx trials Research Report on Larynx

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Durvalumab With Radiotherapy for Adjuvant Treatment of Intermediate Risk SCCHN
Durvalumab, Intensity Modulated Radiotherapy Treatments - Larynx, Lip
Phase 2CompletedUNC Lineberger Comprehensive Cancer Center182019-10-072026-10-22
A Study of Chemo +/- Low-dose Radiation as Induction Therapy in SCCHN
Low dose fractionated radiation - 80cGy with chemotherapy, Docetaxel and Carboplatin AUC 6 - Head and Neck Cancer, Larynx
Phase 2CompletedSusanne Arnold452014-10-012023-03-13

Narrower conditions

Laryngeal Diseases (2)  ·  Head and Neck Neoplasms (1)  ·  Lymphoid Interstitial Pneumonia (1)  ·  Mouth Neoplasms (1)  ·  Neoplasms (1)

Broader conditions

Neoplasms by Site (2)  ·  Otorhinolaryngologic Diseases (2)  ·  Respiratory Tract Diseases (2)  ·  Head and Neck Neoplasms (1)  ·  Mouth Diseases (1)  ·  Neoplasms (1)  ·  Stomatognathic Diseases (1)

Interventions

Docetaxel (1)  ·  Drug Therapy (1)  ·  durvalumab (1)

Sponsors

Susanne Arnold (1)  ·  UNC Lineberger Comprehensive Cancer Center (1)

Countries

United States (2)

Top investigators

Siddharth Sheth, DO MPH (1)  ·  Susanne M Arnold, MD (1)